rethinkPeptides Search
Menu
Research citation

Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.

Diabetes care, 48(12), 2127-2137

Citation

Fang, Yichen E; Paik, Julie M; Ortega-Montiel, Janinne; Tesfaye, Helen; Wexler, Deborah J; Patorno, Elisabetta. (2025). Risk of Acute Pancreatitis and Biliary Events After Initiation of Incretin-Based Medications in Patients With Type 2 Diabetes.. Diabetes care, 48(12), 2127-2137. https://doi.org/10.2337/dc25-1840